Evaluating Portable Oxygen Therapy and Support for Adults With Mild-to-Moderate Fibrotic Interstitial Lung Disease
Led by University of Alberta · Updated on 2026-10-23
60
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating whether portable oxygen therapy during physical activity can improve quality of life, exercise tolerance, shortness of breath, and blood vessel function in patients with fibrotic interstitial lung disease ILD who have normal oxygen levels at rest but develop low oxygen levels with exertion. This study also explores whether adding personalized support through phone calls and educational materials enhances the benefits of oxygen therapy. The study is a phase 2, randomized controlled trial aiming to assess both feasibility and clinical effects.
Participants will be randomly assigned to one of three groups for an 8-week period usual care with no supplemental oxygen, supplemental oxygen during exertion, or supplemental oxygen plus educational support and scheduled phone check-ins with a respiratory educator. Before the intervention, there is a 2-week baseline period, and after the intervention, a 2-week washout period. Study visits include assessments of lung function, exercise tests, vascular function measurements, blood tests, and questionnaires.
Participants will attend seven sessions over about 13 weeks, including baseline testing, intervention, and follow-up visits. They will wear activity and oxygen monitors to track daily physical activity and oxygen levels. Researchers will measure outcomes such as health-related quality of life, exercise tolerance, dyspnea, cough, vascular function, pulmonary artery pressure, cardiac function, and systemic inflammation. The total time commitment for each participant is approximately 12 hours.
CONDITIONS
Brief Title
Ambulatory Oxygen Therapy for Individuals With Mild-to-moderate Interstitial Lung Disease
Research Team
M
Matt Rieger, PhD
D
Desi Fuhr, MSc
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Diagnosed with fibrotic interstitial lung disease (all sub-groups)
Normal oxygen saturation at rest (SpO2 > 90%) but develop low oxygen levels (SpO2 80-89%) during activity measured by 6-minute walk test
You will not qualify if you...
Use of home oxygen therapy within the past year for lung disease or related conditions
Presence of co-morbid conditions requiring oxygen therapy such as COPD or cardiovascular disease
Need for non-invasive ventilation
Significant cardiovascular, metabolic, neuromuscular, or other diseases causing breathing difficulty or abnormal exercise response
Musculoskeletal injuries preventing exercise tests like cycling or walking
Peripheral vascular disease (excluded from vascular function measurements)
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Baseline Assessment
Duration - 2 weeks
Participants undergo initial tests including medical history, lung function, exercise tests, vascular function measurements, blood samples, and questionnaires. They receive activity and oxygen monitors to wear during the study.
3 visits over 2 weeks
Intervention
Duration - 8 weeks
Participants are randomly assigned to one of three groups: usual care, portable oxygen during exertion, or portable oxygen plus additional educational support and phone check-ins. The intervention lasts for 8 weeks.
Multiple visits during intervention
Washout and Follow-up
Duration - 2 weeks
After the intervention, participants enter a 2-week washout period without oxygen therapy. Follow-up assessments repeat earlier tests to measure lasting effects of the intervention.
2 visits during washout
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Similar Trials
Evaluating Portable Oxygen Therapy and Support for Adults With Mild-to-Moderate Fibrotic Interstitial Lung Disease
Optimizing Diagnostic Pathways to Reduce Time to Diagnosis in Suspected Interstitial Lung Disease A Randomized Trial Comparing Standard and Coordinated Diagnostic Circuits
Remote Monitoring to Improve Detection and Care in Interstitial Lung Disease Using Home Devices and Digital Tools
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial.